12th Annual Biomarkers Congress | Manchester
Metabolon is proud to be a Solution Provider Sponsor of the 12th Annual Biomarkers Congress to be held in Manchester, England, February 21-22, 2017. You’ll find us exhibiting in the Solution Provider Pavilion at Booth 11 during the event.
Wednesday, February 22, 2017
Stream 1 | Biomarkers in Drug Discovery & Development, Therapeutic Areas: Cardiovascular, Respiratory, Rheumatology, COPD, Rare Diseases and Microbiome
10:00 – 10:30 am
Location: Conference Room Charter 1
Metabolomics as an Enabling Technology in Biomarker Discovery
Brian R. Keppler, Ph.D., Associate Director, Project Management, Metabolon
- Metabolomics facilitates early diagnosis of disease, prediction of disease progression, monitoring/predicting patient responses to medicines, identification of new drug targets and toxicity profiles.
- Metabolites are sensitive indicators of homeostatic changes and are tightly coupled to the phenotype, making them excellent candidates for biomarkers. Metabolites also play a crucial role in the signaling and regulation of genes, proteins and microbiota, making metabolomics an ideal complement for other forms of -omics research.
- To illustrate, we’ll share examples of biomarker identification, along with potential impact and outcome.
Manchester Central Convention Complex
Directions link: https://www.manchestercentral.co.uk/getting-here